ArticleProstate cancer and prostatic diseases2023

Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study.

Yeva Sahakyan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.